ABSTRACT
antibiotics except aztreonam. 1 MBL producing Gramnegative bacilli, specially Pseudomonas sp, have been increasingly reported in Asia, Europe, Latin American and the United States. [2] [3] [4] [5] Therefore, detection of MBL-producing Gram negative bacilli is crucial for the optimal treatment of patients and to control the spread of resistance.
At present no data is available on MBL producing organisms in Bangladesh. Therefore, the present study was undertaken to detect the prevalence of MBL-producing Pseudomonas in a tertiary care hospital of Dhaka city.
Introduction
Development of antibiotic resistance is a major concern in the management of bacterial infections. Carbapenems are often used as antibiotics of last resort for treating infections due to multi-drug resistant Gram-negative bacilli. They are stable against extended spectrum beta-lactamase (ESBL) and AmC beta-lactamase. However, this scenario is changing with the emergence of metallo--lactamase (MBL) producing strains. The MBLs can efficiently hydrolyze all beta-lactam tested for production of MBL by EDTA-IMP agar dilution MIC method. (Table: 2). 
Discussion
In the present study, about 43% of Pseudomonas isolated from various clinical samples were MBL producers. But it is interesting to note that 61% of MBL producing Pseudomonas were detected among those which showed intermediate resistance to imipenem by MIC. Therefore it appears that these strains could be low level producers of MBL. The clinical outcome of patients infected with such imipenem sensitive, as shown by routine disc diffusion test, but low level MBL producing organisms remains unknown. Similar observation was made in other countries where Klebsiella pneumoniae and Escherichia coli isolated from clinical samples were found carbapenem sensitive but positive for MBL gene. [12] [13] [14] [15] The high rate of MBL positive Pseudomonas in our study was probably due to the fact that majority of our strains were isolated from Intensive Care Units (ICU) samples. In Japan, the rate of resistance to carbapenems increased from 19.3 % in 1998 to 38 % in 2002. 5 A study in a tertiary-care teaching hospital in southern Brazil reported high rates (56.7-58.3%) of imipenem resistance among P. aeruginosa. 15 In Italy, about 20% of all P. aeruginosa and 70% of carbapenem resistant strains contained MBLs. 10 We are unable to determine the trends of MBL producing Pseudomonas in clinical specimens as our study was the first to detect MBLs producing organisms from clinical specimens in Bangladesh. study was carried out during December, 2008 to June, 2009. The specimens included were pus, blood, urine and tracheal aspirates. Production of MBL was tested in Pseudomonas sp only.
Microbiological methods
All samples were routinely cultured on MacConkey and blood agar plates. Blood culture was done by lytic centrifugation method. 6 All suspected colonies of Pseudomonas were identified by Gram staining, colony characteristics, positive oxidase test, motility and standard biochemical reactions. 7 Antibiotic susceptibility testing Antimicrobial susceptibility testing of the isolated organisms was done by a disk diffusion method using the Kirby-Bauer technique 8 and as per the recommendations of the NCCLS. 9 All disks were obtained from Oxoid Ltd., Basingstoke, Hampshire, UK. Antibiotic potency of the disks was standardized against the reference strain, Pseudomonas aeuruginosa ATCC 25853.
Detection of MBL production
Production of MBL by Pseudomonas spp. is determined by EDTA-imipenem (EDTA-IMP) agar dilution MIC reduction method. 10 The EDTA-IMP agar dilution MIC reduction test was a modification of EPI microdilution MIC test as described by Migliavacca et al. 11 The test was used as gold standard for detection of MBLs production in this study.
Briefly, MIC of imipenem of isolated Pseudomonas sp was determined with or without EDTA of defined concentration. First, MIC of imipenem of test organisms was performed by agar dilution method with imipenem concentration between 0.125-1024 mg/ml. Then, again MIC of imipenem of test organism was determined in presence of combination of imipenem and 0.4mM EDTA. Muller-Hinton agar plates were prepared with suspensions of 0.125mg/ml, 0.25mg/ml, 0.5mg/ml, 1mg/ml, 2mg/ml, 8mg/ml, 16mg/ml, 32mg/ml, 64mg/ml, 128 mg/ml, 256 mg/ml, 512 mg/ml, 1024 mg/ml imipenem plus 0.4mM EDTA. A fixed inoculum of 10 4 cfu of the test strains was inoculated on these plates. The reading was taken after 24 hours of incubation. The highest dilution that inhibited the growth of the organism was taken as MIC of the test organism. An organism was considered MBL positive if the MIC of imipenem was reduced by fourfold or more in presence of EDTA compared to MIC of imipenem alone.
Result
A total of 44 Pseudomonas were isolated from various clinical samples of which 08 (18.2%) were sensitive, while 13 (29.5%) and 23 (52.3%) were intermediate resistant (MIC = 8 µg/ml) and resistant (MIC 16 µg/ml) to imipenem respectively (Table-1 ). All 44 Pseudomonas isolates were
